Skip to content
Clinical Trials – home

Doxycycline Monohydrate: A Comprehensive Guide for Patients

4 / 8
trials open to patients / all trials
11+
Countries

In short

This article explores the use of Doxycycline Monohydrate in various clinical trials. These studies primarily focus on assessing the bioequivalence of different formulations of the drug under various conditions, such as fasting and fed states. Additionally, we'll look at its potential application in treating certain medical conditions. The trials aim to compare the absorption rates and effectiveness of different brands and formulations of Doxycycline Monohydrate, providing valuable insights for both healthcare professionals and patients.

At a glance

Main Focus
Bioequivalence studies of Doxycycline Monohydrate formulations
Formulations Studied
Tablets, capsules, oral suspensions
Conditions
Fasting and fed states
Key Measurements
Cmax, AUC (Area Under the Curve)
Dosages
Ranging from 25mg to 150mg
Study Designs
Mostly crossover studies with healthy volunteers
Treatment Potential
Explored for Cutaneous T-cell Lymphoma (CTCL)
Duration
Mostly single-dose studies; CTCL study up to one year
Outcomes
Bioequivalence assessment, efficacy in CTCL, quality of life measures

What is Doxycycline Monohydrate?

Doxycycline Monohydrate is an antibiotic medication that belongs to the tetracycline class of drugs. It's also known by brand names such as Monodox, Adoxa, and Vibramycin. This medication is used to treat various bacterial infections and has been the subject of numerous clinical trials to evaluate its effectiveness and proper usage.

Medical Uses

Doxycycline Monohydrate is prescribed for several medical conditions, including:

  • Acne Vulgaris: It's commonly used to treat moderate to severe acne. In some studies, it has been combined with other compounds like S-equol to enhance its effectiveness in treating acne.
  • Cutaneous T-cell Lymphoma (CTCL): This is a type of cancer affecting the skin. Ongoing research is evaluating the efficacy of Doxycycline in treating relapsed cases of CTCL, including specific types like Mycosis Fungoides and Sezary Syndrome.

While these are specific examples from the clinical trials, it's important to note that Doxycycline is a broad-spectrum antibiotic, meaning it can be effective against a wide range of bacterial infections.

How It's Administered

Doxycycline Monohydrate comes in various forms and dosages:

  • Capsules: Usually available in 50mg and 100mg strengths.
  • Tablets: Available in various strengths, including 100mg and 150mg.
  • Oral Suspension: For those who have difficulty swallowing pills, it's available as a liquid suspension, typically 25mg per 5mL.

The dosage and duration of treatment depend on the specific condition being treated and the patient's individual needs. For instance, in some acne studies, it was administered twice daily.

Bioequivalence Studies

Several studies have been conducted to compare different formulations of Doxycycline Monohydrate. These bioequivalence studies aim to ensure that different brands or formulations of the drug deliver the same amount of active ingredient to the body.

Bioequivalence is measured by comparing certain parameters:

  • Cmax: The maximum concentration of the drug in the blood
  • AUC: Area Under the Curve, which represents the total exposure to the drug over time

These studies help ensure that generic versions of the drug are as effective as brand-name versions.

Effects of Food on Absorption

The absorption of Doxycycline Monohydrate can be affected by food. Some studies have specifically looked at how the drug is absorbed under fasting conditions (when no food has been eaten) versus fed conditions (after a meal).

In some cases, taking the medication with food might help reduce stomach upset, a common side effect. However, it's important to follow your doctor's or pharmacist's instructions, as food can sometimes interfere with the absorption of certain medications.

Ongoing Research

Researchers continue to explore new uses for Doxycycline Monohydrate. For example, a study is investigating its potential in treating Cutaneous T-cell Lymphoma (CTCL), a type of skin cancer. This research aims to determine if Doxycycline could be an effective treatment for patients whose CTCL has returned after previous treatment.

Potential Side Effects

While the clinical trials data provided doesn't extensively discuss side effects, it's important to be aware that all medications can have potential side effects. Common side effects of Doxycycline may include:

  • Nausea or stomach upset
  • Sensitivity to sunlight
  • Headache

Always discuss potential side effects with your healthcare provider before starting any new medication.

Questions people often ask

Conditions where Doxycycline Monohydrate is being studied

Each condition opens its own overview and trial list

Trials with Doxycycline Monohydrate

Recruiting trials first

See all 8 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).